Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Hyperfractionated Radiation Therapy With or Without Simultaneaous Application of CIS-Platinum in Patients With Moderately Advanced to Advanced Cancers of the Head and Neck

NCT00002654 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT00002654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Hyperfractionated Radiation Therapy With or Without Simultaneaous Application of CIS-Platinum in Patients With Moderately Advanced to Advanced Cancers of the Head and Neck
Lead sponsor
Swiss Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
April 30, 1994
Completion date
July 31, 2000
Enrollment
224 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer